Author: digi

Biologics Drug Product GMP: Protein Stability, Aggregation and Contamination Control Biologics Drug Product GMP: Ensuring Protein Stability, Aggregation and Contamination Control Across Dosage Forms Biologics drug products present critical manufacturing challenges distinct from small-molecule pharmaceuticals, stemming primarily from the complex nature of proteins and related macromolecules. Control of protein stability, prevention of aggregation, and robust…

Read More “Biologics Drug Product GMP: Protein Stability, Aggregation and Contamination Control” »

Monoclonal Antibody Drug Products: GMP Controls for Formulation and Filling Ensuring GMP Compliance in Formulation and Filling of Monoclonal Antibody Drug Products Monoclonal antibody (mAb) drug products are a vital class of biopharmaceuticals with significant therapeutic applications. Due to their complex nature and route of administration, robust Good Manufacturing Practice (GMP) controls are critical during…

Read More “Monoclonal Antibody Drug Products: GMP Controls for Formulation and Filling” »

Biosimilar Drug Product GMP: Comparability, Consistency and Lifecycle Controls Biosimilar Drug Product GMP: Ensuring Comparability, Consistency, and Lifecycle Controls Manufacturing biosimilar drug products in compliance with Good Manufacturing Practice (GMP) demands rigorous adherence to regulatory requirements spanning multiple dosage forms. This tutorial presents a comprehensive, step-by-step approach for pharmaceutical professionals tasked with ensuring the GMP-compliant…

Read More “Biosimilar Drug Product GMP: Comparability, Consistency and Lifecycle Controls” »

Small-Volume Parenterals: GMP Controls for Fill Volume and Particulate Matter Ensuring GMP Compliance in Small-Volume Parenterals: Effective Controls for Fill Volume and Particulate Matter Small-volume parenterals (SVPs) represent a critical category of dosage forms that demand rigorous GMP controls to guarantee patient safety and product quality. Unlike solid oral dosage forms such as tablets or…

Read More “Small-Volume Parenterals: GMP Controls for Fill Volume and Particulate Matter” »

Large-Volume Parenterals: Sterility, Pyrogen Control and Container Integrity Ensuring GMP Compliance in Large-Volume Parenterals: A Step-by-Step Tutorial on Sterility, Pyrogen Control, and Container Integrity Large-volume parenterals (LVPs) play a critical role in pharmaceutical therapy, serving as primary vehicles for intravenous administration. Given their mode of delivery directly into the bloodstream or body cavities, ensuring strict…

Read More “Large-Volume Parenterals: Sterility, Pyrogen Control and Container Integrity” »

Ready-to-Use vs Lyophilized Injectables: GMP Considerations for Each Pathway Pharmaceutical GMP Tutorial: Ready-to-Use vs Lyophilized Injectables In pharmaceutical manufacturing, parenteral dosage forms such as sterile injectables require stringent compliance with Current Good Manufacturing Practice (GMP) regulations due to their critical application and patient safety implications. Among parenteral dosage forms, two key pathways exist: ready-to-use injectables…

Read More “Ready-to-Use vs Lyophilized Injectables: GMP Considerations for Each Pathway” »

Prefilled Syringes: GMP Controls for Fill Accuracy, Stopper Movement and Integrity Step-by-Step GMP Controls for Prefilled Syringes: Ensuring Fill Accuracy, Stopper Movement, and Container Integrity Prefilled syringes represent a critical and rapidly expanding dosage form within pharmaceutical manufacturing, bridging the complexity of parenteral products with demands for patient convenience, safety, and precise dosing. Due to…

Read More “Prefilled Syringes: GMP Controls for Fill Accuracy, Stopper Movement and Integrity” »

Cartridges and Dual-Chamber Systems: GMP Risks in Assembly and Storage Comprehensive Guide to GMP Risks in Assembly and Storage of Cartridges and Dual-Chamber Systems The increasing utilization of advanced dosage forms such as cartridges and dual-chamber systems presents unique challenges and risks under Good Manufacturing Practice (GMP) regulations. These assembly and storage processes, applied across…

Read More “Cartridges and Dual-Chamber Systems: GMP Risks in Assembly and Storage” »

Transdermal Patches: GMP Controls for Adhesion, Dose Uniformity and Residues GMP Controls for Transdermal Patches: A Step-by-Step Tutorial on Adhesion, Dose Uniformity, and Residue Management Transdermal patches represent an increasingly important pharmaceutical dosage form, combining the challenges of topical, solid oral, and parenteral product categories. Ensuring comprehensive Good Manufacturing Practice (GMP) controls specific to transdermal…

Read More “Transdermal Patches: GMP Controls for Adhesion, Dose Uniformity and Residues” »

Dermatological Products: Microbial Limits, Preservative Systems and Packaging GMP Step-by-Step GMP Guide for Dermatological Products: Microbial Control, Preservatives, and Packaging Pharmaceutical manufacturers specializing in dermatological products must navigate complex Good Manufacturing Practice (GMP) requirements to ensure safety, efficacy, and quality. Unlike solid oral dosage forms or parenteral preparations, topical formulations present unique challenges, particularly in…

Read More “Dermatological Products: Microbial Limits, Preservative Systems and Packaging GMP” »